Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yayun Xu

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Lancet (London, England)|February 7, 2026
Switch to fixed-dose doravirine (100 mg) and islatravir (0·25 mg) once daily in virologically suppressed adults with HIV-1 on bictegravir, emtricitabine, and tenofovir alafenamide: 48-week results of a phase 3, multicentre, randomised, controlled, double-blind, non-inferiority trialAmy E Colson, Anthony M Mills, Moti N Ramgopal, et al.
Nature Metabolism|January 29, 2024
Obesity causes mitochondrial fragmentation and dysfunction in white adipocytes due to RalA activationWenmin Xia, Preethi Veeragandham, Yu Cao, et al.
Eclinicalmedicine|January 31, 2024
Development of a machine learning-based model to predict hepatic inflammation in chronic hepatitis B patients with concurrent hepatic steatosis: a cohort studyFajuan Rui, Yee Hui Yeo, Liang Xu, et al.
The New England Journal of Medicine|March 6, 2023
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial HypertensionMarius M Hoeper, David B Badesch, H Ardeschir Ghofrani, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 21, 2024
Machine Learning-Based Models for Advanced Fibrosis and Cirrhosis Diagnosis in Chronic Hepatitis B Patients With Hepatic SteatosisFajuan Rui, Liang Xu, Yee Hui Yeo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 10, 2021
2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysisMichael H Le, Yee Hui Yeo, Xiaohe Li, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Lancet (London, England)|February 7, 2026
Switch to fixed-dose doravirine (100 mg) and islatravir (0·25 mg) once daily in virologically suppressed adults with HIV-1 on bictegravir, emtricitabine, and tenofovir alafenamide: 48-week results of a phase 3, multicentre, randomised, controlled, double-blind, non-inferiority trialAmy E Colson, Anthony M Mills, Moti N Ramgopal, et al.
Nature Metabolism|January 29, 2024
Obesity causes mitochondrial fragmentation and dysfunction in white adipocytes due to RalA activationWenmin Xia, Preethi Veeragandham, Yu Cao, et al.
Eclinicalmedicine|January 31, 2024
Development of a machine learning-based model to predict hepatic inflammation in chronic hepatitis B patients with concurrent hepatic steatosis: a cohort studyFajuan Rui, Yee Hui Yeo, Liang Xu, et al.
The New England Journal of Medicine|March 6, 2023
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial HypertensionMarius M Hoeper, David B Badesch, H Ardeschir Ghofrani, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 21, 2024
Machine Learning-Based Models for Advanced Fibrosis and Cirrhosis Diagnosis in Chronic Hepatitis B Patients With Hepatic SteatosisFajuan Rui, Liang Xu, Yee Hui Yeo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 10, 2021
2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysisMichael H Le, Yee Hui Yeo, Xiaohe Li, et al.
Pageof 9